Acasti Pharma Inc. (NASDAQ:ACST – Get Free Report) was the target of a significant growth in short interest in October. As of October 15th, there was short interest totalling 154,200 shares, a growth ...

Despite numerous therapeutic research efforts, treatment of BV remains cumbersome and clinicians are currently rather poorly armed to treat BV properly in the long run. Moreover, appraisal of the ...

This meta-analysis includes 10 RCTs that assess the efficacy of CHX gel to prevent the incidence of alveolar osteitis after mandibular third molar extraction. The control group receives only ...